医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Society5.0 Acquires a Business Model Patent to Build an AR System That Uses Voice Recognition Technology to Provide Medical Safety, Contributing to the Realization of DX

2021年08月03日 PM02:00
このエントリーをはてなブックマークに追加


 

TOKYO

Society5.0, LLC (representative member: Ayako Kinoshita) announces acquisition of a business model patent that involving an AR system that uses voice recognition technology to provide real-time medical safety information to smart glasses and tablet devices.

This technology is expected not only to revolutionize the way medical professionals work, but also to contribute to the realization of DX. Going forward, the company plans to recruit business firms to implement this business model, and it will focus on development for the DX concept.

[Background]

Current medical care is supported by the expertise and sense of responsibility of individual medical professionals. However, people do forget the knowledge and information they have acquired over time. With the advancement and diversification of medical care, navigation systems and robots that assist medical professionals have become the trend of the times.

[Patent Acquired]

“Information providing system, information providing apparatus, information providing method, and information providing program” (Patent No. JP,6607506,B)
Right holders: Society5.0, LLC and others

[Patent Summary]

The scope of this patent is general medical care inside and outside the hospital, health care, and home (remote) medical care. This is a medical support tool that uses voice recognition technology to display (input and output) the various information needed by medical professionals (i.e., patient information, medical technology, and procedures necessary for the task at hand) to smart glasses and or tablet devices via voice commands.

It provides real-time information to help medical professionals speed up their work, should they forget a medical technology procedure. Moreover, the image recognition function (AI) utilizing the device’s camera can also be expected to contribute to recognizing the accuracy of the work and evaluating safety by themselves.

[Future Activities]

In addition to recruiting business firms, we will also focus on recruiting production companies and organizations that provide real-time information and content.

[Profile of Society5.0, LLC]

Company name:

Society5.0, LLC

Representative member:

Ayako Kinoshita

Established:

April 2021

Address:

1-9-36 Konan, Minato-ku, Tokyo, 108-0075, Japan

Expert Office Shinagawa, A,RE,A Shinagawa, 13F, Room 801

Contact:

info@llc-society5.com

Website:

https://www.llc-society5.com

Description of Business:

(1) XR (AR, VR, MR) and AI systems,

(2) Video and audio contents,

(3) Local 5G, IoT, and robotics,

(4) Patent application and royalty management,

(5) Education and training, lectures, etc.

*Voice recognition is a technology or process that analyzes digitized voice data, which includes human speech, and extracts the contents of the speech as text data. It is one of the text input methods for computers.

*AR (augmented reality) is a collective term given to technologies that add, reduce, or modify via computer processing the information provided to the senses of sight, hearing, touch, and other senses from a real environment.

*DX (digital transformation) is the process by which a company responds to the rapid changes in the business environment by using data and digital technologies to innovate products, services, and business models based on the needs of customers and society, while also transforming its very business operations, organization, processes, and corporate culture and environment to establish a competitive advantage.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210802005851/en/

CONTACT

Customer Inquiries

Contact name: Ayako Kinoshita

Society5.0, LLC  

TEL: +81-(0)80-5011-0283

Email: info@llc-society5.com

https://www.llc-society5.com/contact/

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表